US 11535869
CD8-specific antibody constructs and compositions thereof
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 11535869 (CD8-specific antibody constructs and compositions thereof) held by Sana Biotechnology, Inc. expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sana Biotechnology, Inc.
- Grant date
- Tue Dec 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K2239/31, A61K38/00